Why quality of life measurement is important in dermatology clinical practice: An expert-based opinion statement by the EADV Task Force on Quality of Life

TY - JOUR

T1 - Why quality of life measurement is important in dermatology clinical practice

T2 - An expert-based opinion statement by the EADV Task Force on Quality of Life

AU - Finlay, A Y

AU - Salek, M S

AU - Abeni, D

AU - Tomás-Aragonés, L

AU - van Cranenburgh, O D

AU - Evers, A W M

AU - Jemec, G B E

AU - Linder, D

AU - Manolache, L

AU - Marrón, S E

AU - Prinsen, C A C

AU - Susitaival, P

AU - Chernyshov, P V

AU - EADV Task Force on Quality of Life

N1 - © 2016 European Academy of Dermatology and Venereology.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - The aim of this study was to describe the many ways in which quality of life (QoL) measurement may potentially be advantageous in routine clinical dermatology practice. Thirteen members of the EADV Task Force on Quality of Life, eight dermatologists, three health psychologists, one epidemiologist and one pharmacoepidemiologist, independently listed all of the ways they thought this may be advantageous. A total of 108 different ways of using QoL information in clinical practice were suggested (median per participant = 8, range = 4-15), and were classified into 20 descriptive groups. These were sorted into the following five categories: inform clinical decisions, clinician-patient communication, awareness of skin disease burden, informing the consultation and clinical service administration. The wide range of potential benefits identified may not only encourage clinicians to use these measures but also highlights many areas requiring evidence to establish the true value of routine use of QoL measures.

AB - The aim of this study was to describe the many ways in which quality of life (QoL) measurement may potentially be advantageous in routine clinical dermatology practice. Thirteen members of the EADV Task Force on Quality of Life, eight dermatologists, three health psychologists, one epidemiologist and one pharmacoepidemiologist, independently listed all of the ways they thought this may be advantageous. A total of 108 different ways of using QoL information in clinical practice were suggested (median per participant = 8, range = 4-15), and were classified into 20 descriptive groups. These were sorted into the following five categories: inform clinical decisions, clinician-patient communication, awareness of skin disease burden, informing the consultation and clinical service administration. The wide range of potential benefits identified may not only encourage clinicians to use these measures but also highlights many areas requiring evidence to establish the true value of routine use of QoL measures.

KW - Clinical Decision-Making

KW - Communication

KW - Cost of Illness

KW - Dermatology/organization & administration

KW - Humans

KW - Patient Comfort

KW - Physician-Patient Relations

KW - Prognosis

KW - Quality of Life

KW - Referral and Consultation

KW - Skin Diseases/complications

KW - Surveys and Questionnaires

U2 - 10.1111/jdv.13985

DO - 10.1111/jdv.13985

M3 - Review

C2 - 27684717

SN - 0926-9959

VL - 31

SP - 424

EP - 431

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

IS - 3

ER -